Display options
Share it on

Middle East J Dig Dis. 2017 Jan;9(1):55-57. doi: 10.15171/mejdd.2016.52.

Type II Enteropathy-Associated T-cell Lymphoma: A Rare Report from Iran.

Middle East journal of digestive diseases

Neda Nozari

Affiliations

  1. Researcher, Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran ; Shahid Rajai Hospital, Alborz University of Medical Sciences, Karaj, Iran.

PMID: 28316767 PMCID: PMC5308136 DOI: 10.15171/mejdd.2016.52

Abstract

Type II enteropathy-associated T-cell lymphoma (EATL) is a rare disease that is reported from Asia, especially from Taiwan. In this paper, we present a patient from Iran (Arab) with Type II EATL whose disease was not associated with celiac disease or Epstein-Barr virus (EBV) infection. The patient died due to intestinal perforation during the first chemotherapy. Type II EATL is a gastrointestinal lymphoma with poor prognosis and a high affinity for intestinal perforation. Early detection of EATL II is essential for chemotherapy prior to the onset of malnutrition symptoms.

Keywords: Intestinal perforation; Non-Hodgkin lymphoma; T cell lymphoma

Conflict of interest statement

CONFLICT OF INTEREST The author declares no conflict of interest related to this work.

References

  1. Korean J Pathol. 2014 Dec;48(6):426-9 - PubMed
  2. Case Rep Oncol. 2009 Feb 28;2(1):36-43 - PubMed
  3. Blood. 2011 Jul 7;118(1):148-55 - PubMed
  4. Dig Liver Dis. 2013 May;45(5):377-84 - PubMed
  5. BMJ Case Rep. 2015 Jan 07;2015:null - PubMed

Publication Types